Mead Johnson Nutrition CO

Mead Johnson Nutrition — Barclays Capital Back-to-School Consumer Conference 2012

39 slides from Mead Johnson Nutrition's conference presentation, Sep 5, 2012

  1. Slide 1: Barclays Capital Back-to-School Consumer Conference

    Slide 1: Barclays Capital Back-to-School Consumer Conference

    Barclays Capital Back-to-School Consumer Conference September 6, 2012 Boston Pete Leemputte Executive Vice President and CFO Steve Golsby President and Chief Executive Officer

  2. Slide 2: Global, focused pediatric nutrition company

    Slide 2: Global, focused pediatric nutrition company

    2 2 Only competitor solely focused on pediatric nutrition Over 70 products marketed in more than 50 markets Enfa: The leading global brand in high-growth category Strong marketing and science-based product innovation Manufacturing and R&D facilities in Asia, Latin America, U.S. and Europe Mead Johns

  3. Slide 3: Broad Product Offering

    Slide 3: Broad Product Offering

    3 With a comprehensive portfolio of Specialty, Solutions, Routine Infant and Children’s products Broad Product Offering

  4. Slide 4: Growth Industry

    Slide 4: Growth Industry

    4 Source: ERC market report (June 2012). Growth Industry $28 $41 0 5 10 15 20 25 30 35 40 45 2012 E 2017 E Asia Latin America North America Europe ME/Africa Total $6.5 $3.0 $1.2 $1.5 $0.7 $12.9 Growth 2012E - 2017E ` ` ` 50% 23% 10% 12% 5% 100% % of Total Growth Retail Market Sales ($B) Retail Marke

  5. Slide 5: Key Drivers of Long Term Growth

    Slide 5: Key Drivers of Long Term Growth

    5 5 Premiumization Product Innovation Economic Growth Favorable Demographics Growing economies Rising disposable income/dual-income families Increasing awareness of the role of early nutrition in lifelong health Consumers value the nutritional benefits of high-quality, premium products Science-based

  6. Slide 6: Key Growth Driving Trends

    Slide 6: Key Growth Driving Trends

    6 6 * Source: CIA World Fact Book. Favorable Demographics Premiumization Economic Growth Key Growth Driving Trends GDP per Capita GDP per Capita (2010) $ CAGR: 2005 - 2010 United States $47,153 2% Brazil $10,710 18% Mexico $9,133 3% Argentina $9,124 14% Malaysia $8,373 10% Peru $5,401 13% Thailand $

  7. Slide 7: Focus on Premium Segment

    Slide 7: Focus on Premium Segment

    7 Enhanced nutritional profile relative to non-premium products Greater ability to innovate and deliver new benefits within this segment Higher potential to absorb input cost increases during high inflation periods Premium Segment Participation Benefits *Note: Estimates based on June 2011 Nielsen da

  8. Slide 8: Births and Industry Consumption

    Slide 8: Births and Industry Consumption

    8 8 Births and Industry Consumption * IF-GUM is defined as Infant Formula and Growing Up Milk Sources: ERC market report (June 2012); CIA World Fact Book. 2011 IF/GUM* Volume Consumption Kilograms per Birth 47 35 20 12 7 0 10 20 30 40 50 North America W. Europe Asia Latin America BRI 2011 Birth Rate

  9. Slide 9: Scientific Research Drives Innovation

    Slide 9: Scientific Research Drives Innovation

    Scientific Research Drives Innovation Mead Johnson has a long history of science-based product innovation. 9 Respiratory Health Immune Health Allergy Management Cognitive Development More than a decade of clinical studies demonstrating improved cognitive development through 18 months of age Propriet

  10. Slide 10: Absolute Commitment to Quality

    Slide 10: Absolute Commitment to Quality

    Absolute Commitment to Quality U.S. TV Commercial QUALITY CHECKS AND SAFETY TESTS 2300 OF PEDIATRIC NUTRITION EXPERTISE 100 YEARS 10

  11. Slide 11: Strong Pipeline of Innovation

    Slide 11: Strong Pipeline of Innovation

    11 Strong Pipeline of Innovation Products Launched in 2011 Products Launched in 2012

  12. Slide 12: Proven Demand Generation Model

    Slide 12: Proven Demand Generation Model

    12 12 Source for claim: Wolters Kluwer Pharma Solutions Consumer Products Group Performance Measurement Report Proven Demand Generation Model In-Store Display / Education Digital Mobile In - Store In - Store In - Hospital and with HCPs In - Hospital and with HCPs At Home At Home New Facebook HCP/Hos

  13. Slide 13: Strong Financial Performance

    Slide 13: Strong Financial Performance

    13 All data shown on a non-GAAP basis. See the appendix for a reconciliation of GAAP to non-GAAP data. Strong Financial Performance Sales, $ Billion EPS +9% +9% +3% +3% +10% +10% Sales Growth (Excluding F/X) +14% +14% +7% +7% $1.63 $1.72 $1.90 $2.23 $2.42 $2.79 $2.3 $2.5 $2.8 $2.8 $3.1 $3.7 2006 200

  14. Slide 14: The China Opportunity

    Slide 14: The China Opportunity

    14 The China Opportunity Data Sources: Category Growth: Nielsen retail audit panel by June 2012 13% 8% 13% 7% 7% 8% 0% 5% 10% 15% 1Q 11 1Q 12 3Q 11 2Q 12 2Q 11 4Q 11 World ’ s Largest Market An $8 billion retail category currently growing at 7 - 8% World ’ s Largest Market World ’ s Largest Market A

  15. Slide 15: China market share

    Slide 15: China market share

    15 15 China* : for Mead Johnson includes China-Hong Kong Market Share %: Nielsen retail audit panel by March 2012, with coverage rate adopted. China/Hong Sales: Net Sales for Mead Johnson China/Hong Kong Market Share 0 2 4 6 8 10 12 14 16 18 20 Jul-09 Oct-09 Jan-10 Apr-10 Jul-10 Oct-10 Jan-11 Apr-11

  16. Slide 16: 2012 "Smarties" Product Innovation

    Slide 16: 2012 "Smarties" Product Innovation

    16 2012 “Smarties” Product Innovation Value Share (%) Market #1 – Launched August 2011 Market #1 – Launched August 2011 10% 15% 20% 25% Base Period Mths 1-3 Mths 4-6 Mths 7-9 Value Share (%) Market #2 – Launched October 2011 Market #2 – Launched October 2011 10% 15% 20% Base Period Mths 1-3 Mths 4-6

  17. Slide 17: China Premium Mix

    Slide 17: China Premium Mix

    17 Note: Nielsen retail audit data annual value average. Sales dollars for price tier data based on market-level categorizations of specific brands. China Premium Mix 85% 91% 100% 100% 9% 15% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2009 2011 100% 100% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

  18. Slide 18: United States: Near Term Challenges, Future Optimism

    Slide 18: United States: Near Term Challenges, Future Optimism

    18 “Echo Boom” women have entered the prime childbearing age “Intended” number of children of 2 births per woman has remained roughly consistent for nearly 50 years Newborn recovery slightly faster than earlier expectations However * Nielsen Data includes All Outlets Combined + BJs + DECA for Infant

  19. Slide 19: MJN is an Established Market Leader in Asia

    Slide 19: MJN is an Established Market Leader in Asia

    19 MJN is an Established Market Leader in Asia Greater China Greater China Markets with no direct MJN presence Southeast Asia Southeast Asia • Industry – Large, premium and fast growing • MJN has a strong competitive position with consistent double - digit sales growth • Industry – Large, split prem

  20. Slide 20: Latin America is a Key Pillar of Growth

    Slide 20: Latin America is a Key Pillar of Growth

    20 Source: ERC market report (June 2012) Latin America is a Key Pillar of Growth 2004 2009 2015 Sales $MM USD $1B Latin America Sales Mead Johnson Latin America Sales 8% CAGR 15%+ CAGR • MJN well - positioned in key markets • Focused business development to support growth ambition 0 1 2 3 4 5 2006 2

  21. Slide 21: Growth Opportunities in Latin America

    Slide 21: Growth Opportunities in Latin America

    21 Note: Map reflects markets in which Mead Johnson directly participates. Growth Opportunities in Latin America Mexico • Large market with significant headroom for growth • Our third largest market globally Central and South America • Large, premium market growing at double - digit rate • MJN a lea

  22. Slide 22: Global, focused pediatric nutrition company

    Slide 22: Global, focused pediatric nutrition company

    22 Source: Based on internal company records and trademark registrations. Global, focused pediatric nutrition company Before 1925 1925 - 1950 1951 - 1975 1975 - 2005 New Seeds Before 1925 1925 - 1950 1951 - 1975 1975 - 2005 New Seeds

  23. Slide 23: Financial Overview

    Slide 23: Financial Overview

    23 Financial Overview

  24. Slide 24: Strong Financial Performance

    Slide 24: Strong Financial Performance

    24 Strong Financial Performance All data shown on a non-GAAP basis. See the appendix for a reconciliation of GAAP to non-GAAP data. Sales, $ Billion EPS +9% +9% +3% +3% +10% +10% Sales Growth (Excluding F/X) +14% +14% +7% +7% $1.63 $1.72 $1.90 $2.23 $2.42 $2.79 $2.3 $2.5 $2.8 $2.8 $3.1 $3.7 2006 200

  25. Slide 25: Strong and Diverse Emerging Market Growth

    Slide 25: Strong and Diverse Emerging Market Growth

    25 Strong and Diverse Emerging Market Growth Trend in Sales Growth Rate: H2 vs. H1 2012 Sales Growth CAGR in Constant Dollars (6%) 3% 15% 7% 40% 14% 8% 28% 20%+ ~10% ~20% (2%) North America/Europe Latin America Southeast Asia China/Hong Kong 2006-2010 2011 H1 2012

  26. Slide 26: Inflationary Pressures in 2012

    Slide 26: Inflationary Pressures in 2012

    Inflationary Pressures in 2012 Material Sourcing Priorities • Secure supply • Assure competitive costs • Minimize price volatility • Drive productivity • Enable innovation 2011 COGS: $1,362 Other Raw Materials Agricultural Packaging Conversion Dairy COGS inflation should run in the mid - to - high s

  27. Slide 27: Dairy Spot Prices

    Slide 27: Dairy Spot Prices

    27 27 Dairy Spot Prices Note: WMP = Whole Milk Powder; NFDM = Non-Fat Dry Milk $1.50 $2.50 $3.50 $4.50 Jul 09 Sep 09 Nov 09 Jan 10 Mar 10 May 10 Jul 10 Sep 10 Nov 10 Jan 11 Mar 11 May 11 Jul 11 Sep 11 Nov 11 Jan 12 Mar 12 May 12 Jul 12 $ per kg Monthly Average Spot Dairy Price (No Lag) Europe WMP NA

  28. Slide 28: Importance of Productivity to Gross Margins

    Slide 28: Importance of Productivity to Gross Margins

    28 Importance of Productivity to Gross Margins Target 3% of COGS productivity each year Target 3% of COGS productivity each year Project Examples: • Negotiations with suppliers • Material and formulation changes • Manufacturing efficiencies

  29. Slide 29: Operating Expenses (% of Sales)

    Slide 29: Operating Expenses (% of Sales)

    29 Operating Expenses (% of Sales) All data shown on a non-GAAP basis. Spending as Percentage of Net Sales 14.0% 13.8% 14.1% 2.5% 2.5% 2.5% 2.5% 36.8% 38.6% 39.4% 39.3% 7.5% 8.1% 8.8% 8.5% 14.7% 12.8% 14.2% 14.0% 13.6% 2008 2009 2010 2011 General & Administrative (G&A) spending offers an important s

  30. Slide 30: Effective Tax Rate: Another source of earnings leverage

    Slide 30: Effective Tax Rate: Another source of earnings leverage

    Non-GAAP Based on MJN analysis of GAAP earnings and estimated cash repatriation 30 Effective Tax Rate (ETR) Another source of earnings leverage 2008 2009 2010 2011 37.2% 28.6% 30.1% MJN ETR 1 % of 2010 - 2011 Earnings Repatriated to US 2 60% 40% Repatriated Not Repatriated % of 2010 - 2011 Earnings

  31. Slide 31: Optimizing Asia Supply Chain

    Slide 31: Optimizing Asia Supply Chain

    31 New Singapore Spray Dryer First company-owned spray dryer in Asia Optimizing Asia Supply Chain Cost: $300 million capital over 3 years and about $25 million in expenses Non-GAAP start-up expenses of $0.04 - $0.05 EPS in 2013 Fully Operational by mid-2014 Investment includes a Technology Center an

  32. Slide 32: Strong and Stable Free Cash Flow

    Slide 32: Strong and Stable Free Cash Flow

    32 Strong and Stable Free Cash Flow Adjustment to bring non-GAAP net income to GAAP reported figures, with the exception that the current MJN capital structure has been maintained in all periods shown 2009 2010 Full Year $ in Millions 2009 2010 2011 Net Earnings (Non - GAAP) $468 $504 $584 Specified

  33. Slide 33: Uses of Cash

    Slide 33: Uses of Cash

    33 Uses of Cash Source: Market data as of December 31, 2011 • Our highest priority • Tuck - in acquisitions Growth Growth Returning Cash to Shareholders Returning Cash to Shareholders • Dividend growth > earnings • Share repurchases to offset impact of dilution from employee equity awards LTM Divide

  34. Slide 34: Mead Johnson Strengths

    Slide 34: Mead Johnson Strengths

    34 Mead Johnson Strengths Strong history of sales and EPS growth Excellent growth potential in emerging markets and expanding market diversification Increased investments in demand-generation and innovation Proven delivery of high quality standards Strong and stable cash flow Strong management with

  35. Slide 35: Mead Johnson Nutrition

    Slide 35: Mead Johnson Nutrition

    Meadjohnson” Nutrition

  36. Slide 36: Appendix

    Slide 36: Appendix

    36 Appendix

  37. Slide 37: Reconciliation of GAAP to Non-GAAP

    Slide 37: Reconciliation of GAAP to Non-GAAP

    37 Reconciliation of GAAP to Non-GAAP $ in millions FY FY FY FY FY FY Q1 Q2 Net Sales GAAP $2,345.1 $2,576.4 $2,882.4 $2,826.5 $3,141.6 $3,677.0 $986.6 $1,012.3 Adjustments: Operating Model (35.9) (35.9) (35.9) 0.0 0.0 0.0 0.0 Adjusted Non-GAAP $2,309.2 $2,540.5 $2,846.5 $2,826.5 $3,141.6 $3,677.0 $

  38. Slide 38: Reconciliation of GAAP to Non-GAAP

    Slide 38: Reconciliation of GAAP to Non-GAAP

    38 Reconciliation of GAAP to Non-GAAP In millions, except per share data FY FY FY FY FY FY Q1 Q2 Net Earnings GAAP $404.7 $429.6 $401.0 $410.6 $458.2 $519.0 $169.8 $171.1 Adjustments: Operating model (5.9) (5.9) (5.9) 0.0 0.0 0.0 0.0 0.0 Impairment Charge 15.6 0.0 0.0 0.0 0.0 0.0 0.0 Bad Debt Write-

  39. Slide 39: Mead Johnson Nutrition

    Slide 39: Mead Johnson Nutrition

    Meadjohnson” Nutrition

Source: SEC EDGAR · 8-K filed Sep 5, 2012

More decks from Mead Johnson Nutrition CO